NuVision Biotherapies

NuVision has developed a unique way to process and preserve amnion which can be applied to the surface of the eye to promote healing of ‘front of eye’ disease and trauma.

2014

YEAR FOUNDED

2014

DATE FIRST INVESTED

Biotherapy
School of Medicine

Profile

Prior to NuVision, cryopreserved amnion had to be stored in specialist facilities. Delivery of the amnion had to be within thawing time before surgery which is a constraint for the NHS and meant the treatment could only be used for scheduled surgery.

NuVision’s first product, Omnigen® is a dry, sterile disc that does not require specialist storage conditions.

Omnigen® has further potential for use in human and veterinary treatments for conditions that feature chronic pain or inflammation, and flexible storage conditions potentially make it suitable for remote emergency treatment by military surgeons.